Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Sales | 7,036 | 5,244 | 4,434 | 3,915 | 4,434 |
| Cost of Goods | 1,107 | 837 | 793 | 434 | 79 |
| Gross Profit | 5,929 | 4,407 | 3,641 | 3,481 | 4,355 |
| Operating Expenses | 71,845 | 55,926 | 60,420 | 28,916 | 23,121 |
| Operating Income | -65,809 | -50,682 | -55,986 | -25,001 | -18,686 |
| Interest Expense | 340 | 89 | 0 | -19 | -30 |
| Other Income | 3,499 | -384 | -205 | -325 | 213 |
| Pre-tax Income | -62,650 | -51,155 | -56,191 | -25,306 | -18,444 |
| Income Tax | -4,516 | -7,376 | -3,281 | 0 | 0 |
| Net Income Continuous | -58,134 | -43,779 | -52,910 | -25,306 | -18,444 |
| Minority Interests | -11,143 | -7,367 | -9,026 | -3,880 | -1,928 |
| Net Income | $-46,991 | $-36,412 | $-43,883 | $-21,426 | $-16,516 |
| EPS Basic Total Ops | -0.59 | -0.55 | -0.81 | -0.44 | -0.35 |
| EPS Basic Continuous Ops | -0.73 | -0.66 | -0.98 | -0.51 | -0.39 |
| EPS Diluted Total Ops | -0.59 | -0.55 | -0.81 | -0.44 | -0.35 |
| EPS Diluted Continuous Ops | -0.73 | -0.66 | -0.98 | -0.51 | -0.39 |
| EBITDA(a) | $-59,230 | $-42,002 | $-52,708 | $-21,720 | $-15,778 |